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Pneumococcal galactose 
catabolism is controlled by multiple 
regulators acting on pyruvate 
formate lyase
Firas A. Y. Al-Bayati1,2, Hasan F. H. Kahya1,2, Andreas Damianou1, Sulman Shafeeq3, 
Oscar P. Kuipers3, Peter W. Andrew1 & Hasan Yesilkaya1
Catabolism of galactose by Streptococcus pneumoniae alters the microbe’s metabolism from homolactic 
to mixed acid fermentation, and this shift is linked to the microbe’s virulence. However, the genetic 
basis of this switch is unknown. Pyruvate formate lyase (PFL) is a crucial enzyme for mixed acid 
fermentation. Functional PFL requires the activities of two enzymes: pyruvate formate lyase activating 
enzyme (coded by pflA) and pyruvate formate lyase (coded by pflB). To understand the genetic basis 
of mixed acid fermentation, transcriptional regulation of pflA and pflB was studied. By microarray 
analysis of ΔpflB, differential regulation of several transcriptional regulators were identified, and 
CcpA, and GlnR’s role in active PFL synthesis was studied in detail as these regulators directly interact 
with the putative promoters of both pflA and pflB, their mutation attenuated pneumococcal growth, 
and their expression was induced on host-derived sugars, indicating that these regulators have a role 
in sugar metabolism, and multiple regulators are involved in active PFL synthesis. We also found that 
the influence of each regulator on pflA and pflB expression was distinct in terms of activation and 
repression, and environmental condition. These results show that active PFL synthesis is finely tuned, 
and feed-back inhibition and activation are involved.
Microbes commonly use multiple pathways for metabolism of the same nutrient, very likely due to operation of 
different pathways, that require distinct environmental conditions1,2. The presence of functionally similar path-
ways gives rise to the emergence of different phenotypes. However, the environmental and genetic factors giv-
ing rise to different metabolic outcomes, and hence phenotypes, are poorly understood. The important human 
pathogen Streptococcus pneumoniae is a good example for studying this case. It can exist as a commensal in the 
nasopharynx but also, for incompletely understood reasons, it can be a pathogen, causing diseases with high mor-
bidity and mortality, such as pneumonia, bacteraemia, otitis media and meningitis3. It has been demonstrated by 
several studies that the pneumococcus exhibits different phenotypes in different tissues that enable the microbe 
to colonize mucosal surfaces or enhance its virulence. Changes in operation of its metabolic machinery under the 
influence of tissue-specific environmental conditions and nutrients will be a major contributing factor4,5.
Energetic metabolism has a fundamental influence on pneumococcal colonization and virulence1,2. S. pneu-
moniae produces its energy exclusively through fermentative breakdown of sugars because it lacks a complete 
set of genes required for respiration6. The pneumococcus has the capacity to utilize 32 different sugars7, which 
may provide a selective advantage to the microbe when it encounters different sugars in host tissues. The two 
most abundant sugars for the pneumococcus are glucose in the blood and galactose in the respiratory tract1,2,8. 
Fermentation of each leads to formation of pyruvate, from glycolysis for glucose, and the Leloir or tagatose path-
ways for galactose1. When growing on glucose, homolactic fermentation occurs, with pyruvate being converted 
to lactic acid by lactate dehydrogenase, thus replenishing NAD+. On galactose, however, there is a different met-
abolic outcome. In this instance, pyruvate can be converted to acetyl-CoA and formate by pyruvate formate lyase 
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(PFL)2,9. The formation of acetyl-CoA gives the possibility of formation of an additional ATP via the action of 
acetate kinase or regeneration of two molecules of NAD+ with the formation of ethanol.
We show that utilization of galactose leads to the generation of mixed acids, and that pyruvate formate lyase 
(PFL), converting pyruvate to formate and acetyl-CoA, is the key enzyme for mixed acid fermentation2. Mutation 
of either pflB, which codes for PFL, or pflA, which codes for the pyruvate formate lyase activating enzyme 
(PFL-AE), being responsible for posttranslational activation of inactive PFL, results in abrogation of mixed 
acid fermentation on galactose, and interestingly leads to a decrease in pneumococcal virulence2. Despite the 
importance of PFL activity for pneumococcal metabolism and virulence, transcriptional regulation of the genes 
responsible for active PFL synthesis is not known in detail, neither in pneumococcus nor in other Gram-positive 
bacteria. So far, only the catabolite control protein A (CcpA) has been implicated in regulation of pflB10. However, 
the mechanism of CcpA-exerted pflA and pflB regulation remains to be investigated. Moreover, it is reasonable to 
assume that alternative regulatory systems that are operative independently of CcpA, may also have effect on the 
regulation of pflA and pflB11.
In this study, our objective was to identify the transcriptional regulators (TR) modulating the expression of 
genes responsible for active PFL synthesis in S. pneumoniae. We found that multiple regulators control the tran-
scription of pflA and pflB. We gathered evidence showing that some of these regulators are induced by galactose, 
their control over pflA and pflB is influenced by sodium formate, they exert regulatory influence on each other, 
and are required for pneumococcal colonization and virulence.
Results
Transcriptome analysis of ΔpflB. To identify transcriptional regulators of pflB, the transcriptional profile 
of Δ pflB was obtained during growth on galactose relative to the wild type D39 strain. This analysis revealed dif-
ferential expression of 113 genes in the mutant relative to the wild type (Table 1). The microarray results were val-
idated for selected genes by quantitative real time PCR, and a similar trend of expression was obtained (Table 2). 
Out of these 113 genes, 62 were down-regulated and 51 were up-regulated in Δ pflB. The notable gene classes 
with differential expression were consistent with PFL’s role in galactose metabolism, pyruvate dissimilation, and 
catabolic and anabolic reactions, and included those coding for galactose hydrolysis and sugar uptake (n = 27), 
genes implicated in cell shape (n = 6), and fatty acid biosynthesis and acetate dissimilation (n = 13). Interestingly, 
the expression of loci containing Leloir pathway genes (n = 7) decreased in the mutant, whereas tagatose pathway 
genes were not affected, implying that the two galactose catabolic pathways are governed by distinct regulatory 
processes.
The expression of seven genes annotated as transcriptional regulators was also either significantly up- or 
down-regulated in the mutant relative to the wild type (Table 1). These were, as annotated in the D39 genome 
(http://www.ncbi.nlm.nih.gov), MarR (SPD_0379), GlnR (SPD_0447), GntR (SPD_1524), SPD_1594, PlcR 
(SPD_1745), CcpA (SPD_1797), and NmlR (SPD_1637). These regulators are known to be involved in diverse 
metabolic functions in bacteria, from the control of sugar metabolism (CcpA), fatty acid synthesis (MarR), con-
trol of glutamine metabolism (GlnR), and virulence gene expression (PlcR), to sensing environmental and nutri-
tional cues (GntR)12. Differential expression of the seven transcriptional regulators, including CcpA, led to the 
hypothesis that some of these regulators mediate the expression of pflA or pflB. We could not test our hypothesis 
for SPD_1594 because, despite repeated attempts, this gene could not be mutated, implying that it is likely to be 
essential13.
CcpA, GlnR, and GntR interact with the putative promoters of pflA and pflB. The direct inter-
action of transcriptional regulators with the putative promoters (P) of pflA (PpflA) and pflB (PpflB), was deter-
mined by electrophoretic mobility shift assay (EMSA). For this, recombinant CcpA, PlcR, NmlR, GntR, GlnR, 
and MarR were purified (Supplementary Fig. S1), and their interactions with PpflA and PpflB were studied. The 
results showed that, CcpA and GlnR bound to both PpflA and PpflB. Interaction of transcriptional regulators with 
their target DNA was concentration-dependent and specific, as the regulators could not bind to a gyrB-specific 
probe (Fig. 1a–d). It should be also noted that CcpA binding to PpflA and PpflB occurred without the addition 
of HPr[Ser-P], which is reported to be essential for CcpA-DNA interaction in other lactic acid bacteria14,15. GntR 
could also form complexes with PpflB (Supplementary Fig. S2) but its inducibility with different sugars, and its 
involvement in regulation of pflA and pflB could not be established with subsequent reporter assays. In addition, 
the other transcriptional regulators did not interact either with PpflA or PpflB (data not shown).
PFL activity leads to the generation of up to 35 mM formate when the pneumococcus is propagated on 55 mM 
galactose2. Hence, we tested whether sodium formate would alter the binding affinity of CcpA, and GlnR for 
PpflB. For this, the recombinant proteins were preincubated with 10 mM sodium formate before addition of the 
DNA probe. The results showed that formate enhanced the binding of CcpA to PpflB such that with sodium for-
mate Kd was 0.35 ± 0.09 μ M, and without it was 1.27 ± 0.1 μ M (p < 0.01) (Fig. 2 and Supplementary Fig. S3). The 
effect of formate was specific because the addition of 10 mM Tris-HCl did not have any effect on binding (data 
not shown). On the other hand, formate reduced GlnR (Kd: 0.79 ± 0.1 μ M) affinity for the pflB probe relative to 
without formate (Kd: 0.31 ± 0.09 μ M) (p < 0.01) (Fig. 2).
CcpA and GlnR bind to promoters containing cre sites. After establishing the interaction of CcpA and 
GlnR with PpflA and PpflB, we set out to determine the binding site of these regulators. Initially, we mapped the 
putative binding sites on PpflA and PpflB (Supplementary Fig. S4), and identified multiple sites resembling a cre 
consensus sequence, the known binding site for CcpA from Bacillus subtilis (TGWAARCGYTWNCW, where N 
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GeneID Function Ratioa
SPD_0065 Beta-galactosidase 3 3.2
SPD_0066 PTS system, IIB component 2.6
SPD_0067 PTS system, IIC component 2.4
SPD_0068 PTS system, IID component 2.7
SPD_0069 PTS system, IIA component 1.9
SPD_0094 Hypothetical protein 2.3
SPD_0095 Hypothetical protein 2
SPD_0128 MutT/nudix family protein 2.3
SPD_0145 Hypothetical protein 2
SPD_0148 Ransporter, major facilitator family protein 2.8
SPD_0149 Hypothetical protein 2.2
SPD_0308 ATP-dependent Clp protease, ATP-binding subunit, putative 2
SPD_0423 ROK family protein 2
SPD_0447 Transcriptional regulator, MerR family 2.4
SPD_0448 Glutamine synthetase, type I glnA 2
SPD_0459 Heat shock protein GrpE 3
SPD_0687 ABC transporter, ATP-binding protein 2.9
SPD_0688 Hypothetical protein 2.9
SPD_0915 Iron-compound ABC transporter, iron compound-binding protein 2
SPD_0918 Iron-compound ABC transporter, ATP-binding protein 2
SPD_1375 Hypothetical protein 2.3
SPD_1524 Transcriptional regulator, GntR family 4.1
SPD_1525 ABC transporter, ATP-binding protein 2.2
SPD_1588 Hypothetical protein 2.1
SPD_1589 Hypothetical protein 3
SPD_1590 General stress protein 24, putative 2.6
SPD_1591 Hypothetical protein 2.2
SPD_1594 Transcriptional regulator 2.7
SPD_1595 Hypothetical protein 2.7
SPD_1644 Hypothetical protein 2.1
SPD_1744 Hypothetical protein 2.5
SPD_1745 Transcriptional regulator PlcR, putative 7.1
SPD_1746 Hypothetical protein 13
SPD_1749 Bacteriocin formation protein, putative 9.4
SPD_1750 Hypothetical protein 11.5
SPD_1751 Hypothetical protein 8.1
SPD_1752 Toxin secretion ABC transporter, ATP-binding/permease protein 10.2
SPD_1754 Hypothetical protein 5.5
SPD_1755 Hypothetical protein 5.4
SPD_1756 ABC transporter, ATP-binding protein 3.8
SPD_1756 Hypothetical protein 2.5
SPD_1830 Glycosyl hydrolase, family 1 2
SPD_1831 PTS system, IIC component 2.8
SPD_1832 PTS system, IIB component 2.2
SPD_1943 Hypothetical protein 2.1
SPD_1944 Secreted 45 kd protein 4
SPD_1945 Rod shpae-determining protein MreD, putative 4.6
SPD_1946 Rod shape-determining protein MreC 4.9
SPD_1947 Hypothetical protein 5.5
SPD_1948 ABC transporter, ATP-binding protein 3.7
SPD_1962 Hypothetical protein 11.4
SPD_0116 Hypothetical protein − 3.9
SPD_0161 Hypothetical protein − 2.6
SPD_0262 PTS system, mannose/fructose/sorbose family protein, IID component − 2.3
SPD_0263 manM PTS system, mannose-specific IIC component − 2
SPD_0264 manL PTS system, mannose-specific IIAB components − 1.7
SPD_0378 enoyl-CoA hydratase − 2.7
SPD_0379 Transcriptional regulator, MarR family − 2.3
SPD_0380 3-oxoacyl-(acyl carrier protein) synthase − 2.4
Continued
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GeneID Function Ratioa
SPD_0381 Acyl carrier protein − 2.5
SPD_0382 enoyl-(acyl-carrier-protein) reductase − 3.3
SPD_0383 Acyl-carrier-protein S-malonyltransferase − 3.6
SPD_0384 3-ketoacyl-(acyl-carrier-protein) reductase − 4.3
SPD_0385 3-oxoacyl-(acyl carrier protein) synthase − 5.2
SPD_0386 Acetyl-CoA carboxylase − 4.3
SPD_0387 (3 R)-hydroxymyristoyl ACP dehydratase − 4.6
SPD_0388 Acetyl-CoA carboxylase − 6.3
SPD_0389 Acetyl-CoA carboxylase beta subunit − 5.4
SPD_0390 Acetyl-CoA carboxylase alpha subunit − 5.6
SPD_0407 Hypothetical protein − 2
SPD_0420 Formate acetyltransferase − 2.9
SPD_0471 Pseudo − 2
SPD_0511 5,10-methylenetetrahydrofolate reductase − 2.4
SPD_0652 Branched-chain amino acid ABC transporter, amino acid-binding protein − 1.6
SPD_0653 Branched-chain amino acid ABC transporter, permease protein − 1.9
SPD_0654 Branched-chain amino acid ABC transporter, permease protein − 2.3
SPD_0655 Branched-chain amino acid ABC transporter, ATP-binding protein − 2.7
SPD_0656 Branched-chain amino acid ABC transporter, ATP-binding protein − 2.5
SPD_0727 Hypothetical protein − 2.8
SPD_0728 Hypothetical protein − 2.2
SPD_0729 hemolysin-related protein − 2
SPD_0730 deoD purine nucleoside phosphorylase − 2.5
SPD_0751 Hypothetical protein − 2.3
SPD_0752 Hypothetical protein − 2.9
SPD_0753 pcp pyrrolidone-carboxylate peptidase − 2.9
SPD_0761 Hypothetical protein − 2.1
SPD_0997 hup DNA-binding protein HU − 2.1
SPD_1016 Serine/threonine protein phosphatase − 2
SPD_1101 Signal recognition particle-docking protein FtsY − 1.9
SPD_1102 Cof family protein − 2
SPD_1103 Cof family protein − 1.7
SPD_1301 NADPH-dependent FMN reductase − 2.2
SPD_1302 Oxidoreductase, putative − 2.2
SPD_1360 Hypothetical protein − 2.1
SPD_1514 ABC transporter, ATP-binding protein − 2
SPD_1515 Hypothetical protein − 2.1
SPD_1632 Hypothetical protein − 3.3
SPD_1633 galT− 2 galactose-1-phosphate uridylyltransferase − 2.9
SPD_1634 galK galactokinase − 3.4
SPD_1635 galR galactose operon repressor − 1.9
SPD_1636 Alcohol dehydrogenase, zinc-containing − 2.8
SPD_1637 Transcriptional regulator, MerR family protein − 3.2
SPD_1638 Cation efflux system protein − 3.4
SPD_1667 Oligopeptide ABC transporter, ATP-binding protein AmiF − 2.4
SPD_1668 Oligopeptide ABC transporter, ATP-binding protein AmiE − 2.3
SPD_1669 Oligopeptide ABC transporter, permease protein AmiD − 2
SPD_1670 Oligopeptide ABC transporter, permease protein AmiC − 1.6
SPD_1671 Oligopeptide ABC transporter, oligopeptide-binding protein AmiA − 1.5
SPD_1707 Hypothetical protein − 2.5
SPD_1797 ccpA catabolite control protein A − 2.1
SPD_1965 Choline binding protein PcpA − 5.8
SPD_2021 Glycerol uptake facilitator protein − 2.1
SPD_2033 Ribosomal subunit interface protein − 2.3
Table 1.  Microarray analysis of gene expression in ∆pflB relative to wild type D39 grown anaerobically in 
CDM supplemented with galactose. aRatios ≥ 2 or ≤ − 2.0 (∆ pflB compared with D39 wild type). All P-values 
are < 0.001.
www.nature.com/scientificreports/
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is any base, W is A or T, R is A or G, Y is C or T)16,17. At each putative promoter site, cre1 had the highest level of 
homology to the consensus sequence, 12 out of 14 nucleotides being similar. Therefore, EMSA was performed to 
determine whether cre1 had any role in binding of CcpA, and GlnR. For this, a promoter probe that excluded the 
cre1 sequence was produced and designated as PpflA(cre1−) and PpflB(cre1−), which was similar in size, approx-
imately 100 bp, to the PpflA and PpflB.
EMSA analysis showed that CcpA and GlnR could not bind to PpflB(cre1−), indicating that the 14 nucleotide 
cre sequence located in PpflB contains the binding site for these regulators (Fig. 3a). Conversely, the results show 
that CcpA and GlnR bind to both PpflA and PpflA(cre1−) (Fig. 3b), However, they had higher binding affinities 
for PpflA than for PpflA(cre1−), which has an additional putative cre-like sequence.
GeneID/symbol Function Microarray qRT-PCR
SPD_1797 (ccpA) Catabolite control protein A (CcpA) − 2.1 − 2.1 ± 0.03
SPD_1745 (plcR) Transcriptional regulator, PlcR family 7.1 2.0 ± 0.05
SPD_1637 (nmlR) Transcriptional regulator, MerR family − 3.2 − 2.2 ± 0.05
SPD_1594 Transcriptional regulator 2.7 2.6 ± 0.1
SPD_1524 (gntR) Transcriptional regulator, GntR family 4.1 2.0 ± 0.1
SPD_0447 (glnR) Transcriptional regulator, MerR family 2.4 2.1 ± 0.09
SPD_0379 (marR) Transcriptional regulator, MarR family − 2.3 − 2.3 ± 0.06
SPD_0420 (pflB) Pyruvate formate lyase (PFL) − 2.9 0.0 ± 0.0
Table 2.  Fold difference in expression of genes for transcriptional regulators in S. pneumoniae ΔpflB 
relative to wild type D39 strain grown anaerobically in CDM supplemented with galactosea. aFold difference 
≥ 2 were considered to be significant, ‘− ’ sign indicates down regulation of genes, ‘± ’ represents the standard 
deviation for three individual measurements.
Figure 1. EMSA analysis showing the direct interaction of CcpA (a and b), GlnR (c and d), with PpflB or PpflA, 
respectively. Each lane contains approximately 30 ng PpflB or PpflA. CcpA and GlnR were used between 0.1 to 
0.5 μ M. The coding sequence of gyrB (30 ng) was used as a negative control. Gels were stained with SYBR Green 
EMSA for visualizing DNA.
www.nature.com/scientificreports/
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Host-derived sugars induce the expression of transcriptional regulators. The inducibility of 
the regulators by different sugars was determined using transcriptional reporter assays in anaerobically grown 
cultures. For this, the putative promoter region of each transcriptional regulator was fused to a promoterless 
lacZ in the wild type D39 background, and β -galactosidase activity in resulting reporter strains, PccpA::lacZ-wt, 
and PglnR::lacZ-wt, was determined in the presence of glucose, galactose, mannose, or N-acetyl glucosamine 
(Table 3). All sugars induced the transcriptional regulator-driven β -galactosidase activity relative to expression in 
the absence of sugar (p < 0.01), but the highest inducer was found to be galactose.
In addition, the responsiveness of the regulators to 10 mM sodium formate, which does not affect pneumo-
coccal growth, was also determined. For this, the reporter strains were grown in the presence of glucose because 
formate production was found to be below the detection limit on glucose2,18, hence endogenous formate would 
not interfere with the assay. The results showed that the addition of sodium formate, but not Tris-HCl, induced 
β -galactosidase activity in PccpA::lacZ-wt by 2.4-fold, but decreased the activity in PglnR::lacZ-wt by 4.3-fold 
compared to the activity on glucose alone (Table 3) (p < 0.01). These data indicate that ccpA and glnR expression 
are responsive to formate, and that the absence of formate must be partly responsible for the transcriptional pro-
file of Δ pflB.
CcpA, and GlnR have different roles in expression of pflA and pflB. To test the regulatory roles of 
CcpA, and GlnR on pflA and pflB, PpflA::lacZ and PpflB::lacZ fusions were introduced into both wild type D39, 
and the mutants Δ ccpA, and Δ glnR. The resulting strains PpflA::lacZ-wt, PpflA::lacZ-Δ ccpA, PpflA::lacZ-Δ glnR, 
PpflB::lacZ-wt, PpflB::lacZ-Δ ccpA, and PpflB::lacZ-Δ glnR were tested during anaerobic growth in CDM sup-
plemented with 55 mM of galactose. The results show that β -galactosidase activity in PpflA::lacZ-Δ ccpA and 
PpflA::lacZ-Δ glnR increased by 2.8- and 2.2-fold, respectively, compared to the activity in PpflA::lacZ-wt 
(Fig. 4a) (p < 0.0001), suggesting that CcpA and GlnR repress the transcription of pflA. On the other hand, 
β -galactosidase activity in PpflB::lacZ-Δ glnR increased by 7.2-fold, whereas in PpflB::lacZ-Δ ccpA it decreased by 
28.7-fold compared to the wild type (p < 0.0001) (Fig. 4b), indicating that GlnR repress, and that CcpA activates 
pflB on galactose. On the other hand, on glucose both CcpA and GlnR were found to repress both pflA and pflB, 
Figure 2. EMSA analysis showing the impact of formate on binding affinity of CcpA and GlnR. Sodium 
formate enhanced CcpA- and decreased GlnR affinity for PpflB (b and d, respectively) compared to CcpA  
(a), and GlnR (c) interaction without sodium formate. Each lane contains approximately 30 ng PpflB; 0.2–1.5 μ M  
of CcpA, or GlnR with or without 10 mM sodium formate. The experiment was repeated three times, and a 
representative image is shown.
www.nature.com/scientificreports/
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Figure 3. EMSA analysis showing sequence specificity of CcpA, and GlnR for the cre1 sites in (a) PpflB and  
(b) PpflA. Each lane contains approximately 30 ng of promoter probes, and 0.5 μ M of CcpA or GlnR.
Strains
CDM no 
sugar Glucose Galactose Mannose GlcNAc Glucose + SF
pPP1::lacZ-wt 0.7 ± 0.08 0.4 ± 0.06 1.7 ± 0.04 0.8 ± 0.1 1.4 ± 0.2 0.5 ± 0.07
PccpA::lacZ-wt 12.3 ± 1.3 99.4 ± 1.7 457.7 ± 9.4 125.5 ± 5.5 111.1 ± 4.5 241.4 ± 4.5
PglnR::lacZ-wt 17.3 ± 2.4 89.7 ± 4.4 559.5 ± 15.8 371.9 ± 10.7 118.9 ± 3.8 19.7 ± 0.8
Table 3.  Expression levels (in Miller Units) of pneumococcal transcriptional lacZ-fusions to the promoters 
of transcriptional regulators grown anaerobically in CDM supplemented with 55 mM of glucose, galactose, 
mannose or N-acetyl glucosamine, or 10 mM sodium formate (SF)a. aThe activity is expressed as nmol 
p-nitrophenol/min/ml. Values are the average of at least three independent experiments, each with three 
replicates. ‘± ’ indicates standard error of means (SEM). ‘wt’ indicates wild type D39 strain.
www.nature.com/scientificreports/
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(Fig. 4c and d) (p < 0.001). To rule out the possibility that the expression data was influenced by lacZ fusion, pflA, 
and pflB expression was also determined by real time quantitative reverse transcriptase PCR (qRT-PCR) in Δ 
ccpA and Δ glnR grown on galactose relative to wild type. The results obtained with qRT-PCR were consistent 
with those of the transcriptional reporter assays, ruling out any interference by lacZ (Supplementary Table S1).
Next, we investigated whether CcpA and GlnR could play a regulatory role in each other’s expression. This 
hypothesis was tested by use of EMSA and LacZ reporter assays. EMSA showed that both CcpA and GlnR could 
bind to PccpA, indicating that ccpA regulates its own transcription, and that GlnR is involved in ccpA expression 
(Fig. 5). This binding was specific as CcpA and GlnR could not bind to the putative promoter region of gyrB (lane 
2 in Fig. 1a–d). The interaction between CcpA and GlnR was further investigated by LacZ reporter assays. It was 
shown that β -galactosidase activity in PccpA::lacZ-Δ ccpA and PccpA::lacZ-Δ glnR decreased both on glucose, 
2.5- and 10.3-fold, and on galactose, 30.7- and 1.4-fold, respectively, compared to the activity of PccpA::lacZ-wt 
(Table 4) (p < 0.001). This result shows that both on glucose and galactose CcpA increases its own expression, and 
GlnR activates ccpA, particularly on glucose.
CcpA’s role in regulation of glnR was also determined. CcpA could not bind to PglnR, which was consist-
ent with the lack of a discernible cre sequence in the promoter region. The reporter assay results show that 
β -galactosidase activity in PglnR::lacZ-Δ ccpA decreased by 1.7- and 3.8-fold on glucose and galactose, respec-
tively, compared to PglnR-lacZ-wt. This result suggests that CcpA increases glnR expression in the presence 
of both glucose and galactose, and GlnR does not effect its own expression, since β -galactosidase activity in 
PglnR::lacZ-Δ glnR on glucose (89.7 MU ± 4.4, n = 3) and galactose (572.3 MU ± 4.2, n = 3) was similar to that 
of PglnR::lacZ-wt (with glucose 93.4 MU ± 1.8, and with galactose: 565.0 MU ± 7.1, n = 3 for both) (Table 4). 
Moreover, the results showed that GlnR activates ccpA expression both on glucose and galactose (Table 4).
Figure 4. Expression levels (in Miller Units) of pneumococcal transcriptional lacZ-fusions to the promoters 
of pflA (a and c) and pflB (b and d) in different backgrounds grown anaerobically in CDM supplemented with 
55 mM of galactose (a and b) or glucose (c and d). The activity is expressed as nmol p-nitrophenol/min/ml. 
Error bars show the standard error of the mean for three individual measurements each with three replicates. 
***p < 0.001, ****p < 0.0001.
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Growth and end product analysis. To further investigate CcpA, and GlnR’s role in pneumococcal 
sugar metabolism, the growth profiles and fermentative end-products of Δ ccpA, and Δ glnR were determined. 
Moreover, to evaluate the added impact of CcpA and GlnR mutation on pneumococcal metabolism, a Δ ccpAΔ 
glnR mutant was also constructed and tested. On glucose, Δ ccpA, Δ glnR, and Δ ccpAΔ glnR had significantly 
reduced growth rates (0.36 h−1 ± 0.01, 0.47 h−1 ± 0.01, and 0.31 h−1 ± 0.01 respectively, n = 3) compared to wild 
Figure 5. (a) Schematic representation showing the analysis of predicted promoter region and binding sites 
of PccpA, and (b) EMSA analysis showing the direct interaction of CcpA and GlnR with PccpA. (a) The core 
promoter region containing the − 10 and − 35 elements is indicated. The putative cre sequences are indicated in 
red. F: indicates forward primer while R: refers to the reverse primer used for amplifying the promoter probe. T: 
potential terminator structure. The black arrow presents the direction of transcription. (b) Each lane contains 
approximately 30 ng PccpA; 0.5 μ M of CcpA or GlnR as appropriate.
Strains Glucose Galactose
pPP1::lacZ-wt 0.7 ± 0.05 0.9 ± 0.08
PccpA::lacZ-wt 102.0 ± 1.5 451.2 ± 7.3
PccpA::lacZ-Δ ccpA 40.2 ± 3.0 14.7 ± 2.2
PccpA::lacZ-Δ glnR 9.9 ± 0.2 324.1 ± 10.2
PglnR::lacZ-wt 93.4 ± 1.8 565.0 ± 7.1
PglnR::lacZ-Δ ccpA 53.7 ± 2.5 147.8 ± 13.7
PglnR::lacZ-Δ glnR 89.7 ± 4.4 572.3 ± 4.2
Table 4.  Expression levels (in Miller Units) of pneumococcal transcriptional lacZ-fusions to the promoters 
of ccpA and glnR in different backgrounds grown anaerobically in CDM supplemented with 55 mM of 
glucose or galactosea. aThe activity is expressed as nmol p-nitrophenol/min/ml. Values are average of at least 
three independent experiments each with three replicates. ‘± ’ indicates standard error of means (SEM).
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1 0Scientific RepoRts | 7:43587 | DOI: 10.1038/srep43587
type D39 (0.67 h−1 ± 0.01) (p < 0.0001 for all strains). Despite a low rate of growth, Δ ccpA growth yield (max 
change in OD500), was similar to that of wild type, while Δ glnR had a lower yield than the wild type. In addi-
tion, Δ ccpAΔ glnR had a lower growth rate and yield than each single mutant (p < 0.01) (Fig. 6a). The reason for 
growth attenuation of strains with a glnR mutation, Δ glnR and Δ ccpAΔ glnR, is not known but it may be linked 
to GlnR’s involvement in glucose transport and metabolism.
On galactose, the growth rate and yield of all strains decreased approximately to half or less than that on 
glucose (Fig. 6b). Δ ccpA, Δ glnR, and Δ ccpAΔ glnR had significantly reduced growth rates (0.24 h−1 ± 0.01, 
0.26 h−1 ± 0.01, and 0.07 h−1 ± 0.01, respectively, n = 3) compared to the wild type strain (0.35 h−1 ± 0.01, n = 3) 
(p < 0.01). Δ glnR had an extended lag phase and started to grow after 11 h, which may indicate its involvement in 
sensing of galactose. Moreover, there was significant difference in the rate of growth between Δ ccpAΔ glnR and 
each single mutant (p < 0.001), and the growth yield (max change in OD500) of the double mutant (0.21 ± 0.02, 
n = 3) was significantly lower than that of the single mutants (0.79 ± 0.07 for Δ ccpA, 0.74 ± 0.06 for Δ glnR, n = 3) 
(p < 0.01).
In the presence of glucose the wild type, and Δ glnR strains displayed typical homolactic behaviour with lactate 
as the main fermentation product, and minor amounts of formate and acetate (Fig. 6c). Loss of CcpA in Δ ccpA 
and Δ ccpAΔ glnR caused a shift from homolactic to mixed-acid fermentation. In Δ ccpA, a 4.4-fold increase in the 
yield of formate and 23.5-fold in acetate was detected relative to the wild type. On galactose, the wild type, and Δ 
glnR displayed a mixed-acid fermentation pattern with lactate, formate and acetate as the end products. However, 
Δ ccpA and Δ ccpAΔ glnR had a homolactic product pattern with lactate production in Δ ccpA (29.1 mM ± 0.9, 
n = 3) being significantly higher than in the wild type (p < 0.0001), whereas formate and acetate production in 
these strains was significantly decreased compared to the wild type (p < 0.0001) (Fig. 6d). Therefore, the results 
showed that both transcriptional regulators are important for growth on both glucose and galactose, and CcpA 
has a major impact on the composition of the mixed acid profile.
Figure 6. Pneumococcal growth and fermentation end products after culture anaerobically in CDM 
supplemented with different sugars. (a) shows growth in 55 mM glucose and (b) in galactose. (c) and  
(d) show fermentation end product profiles after growth on glucose and galactose, respectively. Error bars 
show the standard error of the mean for three individual measurements each with three replicates. Significant 
differences were seen comparing the growth rates, and the fermentative profile of mutant strains to the wild type 
D39 using ANOVA followed by Dunnett’s multiple comparison test. **p < 0.01 and ****p < 0.0001.
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Virulence studies. In vitro assays indicated CcpA and GlnR are involved in pflA and pflB regulation, and 
they have a regulatory influence on each other’s expression. Therefore, we determined the contribution of 
CcpA and GlnR to nasopharyngeal colonization, and virulence in mouse models of pneumococcal infection. 
The results show that the median survival time of mice infected intranasally with Δ ccpA, Δ glnR, and Δ ccpAΔ 
glnR (168 h ± 17.3, 168 h ± 13.0 and 168 h ± 0.0 respectively, n = 10) was significantly longer than the wild type 
infected group (35 h ± 13.2, n = 10) (p < 0.001 for all strains) (Fig. 7a). The introduction of intact copies of ccpA 
and glnR into Δ ccpA and Δ glnR, respectively, reconstituted the virulence of these strains with the median sur-
vival times of mice infected with Δ ccpAComp (37 h ± 2.3, n = 10) and Δ glnRComp (45 h ± 19.5, n = 10), being 
not significantly different from the wild type infected cohort (p > 0.05), eliminating the possibility of a polar effect 
of the mutations (Fig. 7a).
The progression of bacteraemia in mice intranasally infected with the pneumococcal strains was also deter-
mined. The concentrations of pneumococci retrieved from the blood are shown in Fig. 7b. The bacterial load in 
the Δ ccpA infected group was significantly lower at 24 and 36 h post-infection (log10 0.18 ± 0.18 CFU/ml and 
log10 0.35 ± 0.2 CFU/ml, respectively, n = 10) compared to the wild type (24 h: log10 4.71 ± 0.6 CFU/ml, 36 h: log10 
5.8 ± 0.3 CFU/ml, n = 10) (p < 0.0001). On the other hand, no bacterial growth could be detected in the blood of 
Δ glnR or Δ ccpAΔ glnR infected animals at 24 and 36 h of infection (p < 0.0001). Moreover, both complemented 
strains, Δ ccpAComp (24 h: log10 4.97 ± 0.5 CFU/ml, 36 h: log10 5.69 ± 0.6 CFU/ml, n = 10) and Δ glnRComp 
(24 h: log10 3.05 ± 0.8 CFU/ml, 36 h: log10 3.6 ± 0.9 CFU/ml, n = 10), had significantly higher loads in the blood of 
infected mice at 24- and 36 h of post infection compared to Δ ccpA and Δ glnR (p < 0.0001) (Fig. 7b).
We also evaluated the contribution of CcpA and GlnR in nasopharyngeal colonization. One hour after infec-
tion of the nasopharynx, the pneumococcal load in the nasopharyngeal tissue for all strains (log10 2.38 ± 0.2 CFU/
mg, log10 2.31 ± 0.4 CFU/mg, log10 2.24 ± 0.6 CFU/mg, log10 2.55 ± 0.5 CFU/mg and log10 2.30 ± 0.3 CFU/mg, 
for Δ ccpA, Δ glnR, Δ ccpAΔ glnR, Δ ccpAComp, and Δ glnRComp, respectively, n = 5) was similar to that of 
wild type (log10 2.44 ± 0.3 CFU/mg, n = 5) (p > 0.05) (Fig. 7c). On the other hand, at 7 days post-infection the 
colony counts for Δ ccpA, Δ glnR, and Δ ccpAΔ glnR (log10 1.24 ± 0.2 CFU/mg, log10 1.52 ± 0.1 CFU/mg and 
log10 0.58 ± 0.1 CFU/mg respectively, n = 5) were significantly lower than the counts of wild type strain (log10 
2.88 ± 0.2 CFU/mg, n = 5) (p < 0.01, p < 0.05 and p < 0.0001 for Δ ccpA, Δ glnR. and Δ ccpAΔ glnR, respectively) 
(Fig. 7c). No significant differences were seen in the bacterial load of the complemented strains, Δ ccpAComp 
and Δ glnRComp (log10 2.96 ± 0.4 CFU/mg and log10 2.74 ± 0.3 CFU/mg respectively, n = 5) compared to the 
wild type (p > 0.05). These results show that CcpA and GlnR contribute both to pneumococcal virulence and 
colonization of nasopharynx.
Discussion
This study provides new insights into how the important human pathogen S. pneumoniae regulates its galactose 
metabolism, which is known to have a major effect on pneumococcal survival in vivo6. Pyruvate formate lyase is 
a key enzyme for pyruvate dissimilation in S. pneumoniae. In addition to its role in pneumococcal energetics, the 
products of the PFL-catalysed reaction, formate, and acetyl CoA, play a key role in anabolic reactions. For exam-
ple, while formate is essential for serine biosynthesis by hydroxymethylation of glycine, acetyl-CoA is important 
for fatty acid biosynthesis2,19. Until this study, very little was known about the transcriptional regulation of genes 
involved in active PFL synthesis.
Our results show that multiple regulators modulate the expression of pflA and pflB. While CcpA and GlnR are 
involved in regulation of both pflA and pflB, GntR could only bind to putative promoter region of pflB. The other 
regulators identified to be differentially expressed in Δ pflB could bind neither to PpflA nor to PpflB, presumably 
their differential expression in Δ pflB was due to indirect effect of pflB mutation. CcpA was found to repress pflA 
and pflB on glucose, and activate pflB and repress pflA expression on galactose. This opposing regulatory influence 
of CcpA on pflA and pflB could indicate that constitutive pflA expression sufficiently activates PFL synthesis. This 
is supported with the fact that the association rate between PFL-AE and PFL is low for biological interactions 
because of large conformational changes when these two enzymes interact. Hence a high level pflA expression 
would be wasteful because of a low association rate20. Moreover, intracellular calculations in E. coli revealed that 
PFL-AE is almost entirely in the PFL-AE/AdoMet PFL pyruvate complex, and its activation requires reduction by 
flavodoxin to initiate catalysis. Therefore, despite its constitutive expression, the existing PFL-AE can be promptly 
activated in this complex when needed. It was also noticed that induction level of PpflA is lower than PpflB on 
galactose (Fig. 4). The expression data are very likely reflecting the amount of PFL-AE required to activate PFL, 
because PFL is completely activated by 0.01 equivalents of PFL-AE in 100 minutes21. The opposing effects of tran-
scriptional regulators on pflA and pflB must be an important pneumococcal adaptation mechanism in tissues with 
different sugar profiles and oxygen concentrations. For example, in an oxygenated environment active PFL is not 
critical as it is sensitive to oxygen. On the other hand, in tissues with high galactose content but limited oxygen 
concentration, the pneumococcus requires mechanisms to induce pflB expression.
In other Gram positive bacteria CcpA binding requires HPr-[Ser-P], while the pneumococcal CcpA bound 
to a cre sequence in the absence of HPr-[Ser-P]22. However, we found that 10 mM sodium formate enhanced 
CcpA affinity for PpflB, consistent with its induction by sodium formate in the transcriptional reporter assays. 
Although the inducibility of ccpA expression by different carbon compounds had been shown previously11,23, this 
is the first demonstration of the responsiveness of this master regulator to formate. It is not clear how formate 
enhances CcpA binding and stimulates the expression, but given that formate is a potent reducing agent, with a 
redox potential of − 420 mV24, it is very likely due to its effect on the conformation or multimerization of protein 
structure. Addition of formate increased ccpA-, and decreased glnR transcription, indicating the responsiveness 
of S. pneumoniae to formate. Formate’s role as a transcriptional signal also shows that the absence of formate is 
partly responsible for the transcriptional profile of Δ pflB. In addition, we previously demonstrated that fatty acid 
composition of S. pneumoniae changes in Δ pflB, which cannot produce formate, also indicating the importance 
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Figure 7. Contribution of CcpA and GlnR to pneumococcal virulence and colonization. (a) Survival time 
of mice infected intranasally with approximately 2 × 106 CFU pneumococci. Each dot represents the survival 
time of individual animal, and the horizontal bars mark the median survival times derived from 10 animals. 
(b) Progression of bacteraemia in mice infected intranasally with Δ ccpA, Δ glnR and their derivatives at 24 h 
and 36 h post-infection. Each point is the mean of data from ten mice. (c) Pneumococcal strains defective in 
ccpA and glnR were less able to colonize nasopharynx. Mice were infected approximately with 1 × 105 CFU 
pneumococci. At day 0 and day 7, five mice were culled, and bacterial CFU/mg were determined by serial 
dilutions of nasopharyngeal homogenates. Each column represents the mean of data from five mice. Error bars 
show the standard error of the mean. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
www.nature.com/scientificreports/
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of formate on transcription and protein synthesis2. Formate was reported to have a major influence on bacterial 
gene expression, and acts as a diffusible signal to induce Salmonella enterica serovar Typhimurium invasion25. In 
Staphylococcus aureus, it was suggested that formate production is necessary for formyl-tetrahydrofolate synthe-
sis, which is required for protein and purine synthesis18. Further work is required to understand the mechanism 
by which formate impacts on the pneumococcus. We did use galactose similarly to formate to determine its effect 
on the affinity of transcriptional regulators to PpflA and PpflB. However, no difference could be detected.
The cre1 within PpflB has been identified to be the binding site for GlnR. GlnR bound two cre sites in PpflA 
but here it had a higher binding affinity for cre1 than cre2. GlnR binding affinity for pflB was shown to decrease in 
the presence of 10 mM sodium formate, consistent with a decrease in PglnR driven β -galactosidase activity with 
sodium formate. This is the first demonstration of interaction of proteins, other than CcpA and HPr, with cre. 
Given that cre sites are plentiful in Gram-positive bacteria, it is plausible that some of these targets are regulated 
by multiple regulators, either independently or in concert with CcpA.
Interestingly, although CcpA plays a role in glnR regulation, as determined by the LacZ reporter assay, 
PglnR does not have an identifiable cre-like sequence. Therefore, it is possible that CcpA-mediated glnR regu-
lation requires the involvement of another, unknown, protein(s). It is known that several genes with no cre or 
un-functional cre have been reported to be indirectly regulated by CcpA26–28. Our results showed that both CcpA 
and GlnR have a significant role in pneumococcal virulence and colonization. The results obtained in this study 
on CcpA’s impact on pneumococcal colonization and virulence are in line with previous reports11,23. However, 
our in vivo results for GlnR differ from the study of Hendriksen et al., who could not attribute a role for GlnR in 
pneumococcal virulence and colonization29. One reason for this discrepancy can be linked to the difference in 
dose-preparation, for example, while in this study we did not passage the bacterial inoculum through peritoneum 
before infection, Hendriksen’s study used passaged bacteria. In vivo passaging before infection can introduce 
mutations to a bacterial population due to strong within-host selective pressure30.
The GntR family of transcriptional regulators is a group of transcriptional repressors distributed among 
diverse bacterial groups, and mediate bacterial response to nutritional and/or environmental signals31. In addi-
tion to CcpA and GlnR, GntR could also bind to PpflB. However, GntR could not bind to PccpA and PpflA, even 
though both have a cre-like sequence. Unlike cre1 in PpflB (TGAAATCGGTTACT, conserved residues are under-
lined), which is categorised as a high-affinity cre box because it contains all four strongly conserved residues, G2, 
C7, G8, and C13, the cre sequences in PpflA, and PccpA contain only 2 or 3, respectively, conserved residues16,17. 
Therefore, it is likely that GntR only recognizes highly conserved cre boxes. PgntR-driven β -galactosidase activity 
was not induced by any of the tested sugar nor Δ gntR is attenuated in growth on galactose (data not shown). This 
suggests that in addition to sugar dependent regulation, sugar independent regulation of pflA and pflB may take 
place.
Figure 8. Schematic model of pflB and pflA regulation. On galactose, formate production by PFL activity 
decreases GlnR affinity for PpflB and GlnR increases ccpA transcription. The increased formate production 
increases CcpA affinity for PpflB, and CcpA either alone or after interacting with GlnR binds to PpflB and 
increases pflB transcription. However, CcpA also binds to PpflA and represses its expression to fine-tune the 
level of active PFL. Increased formate production then creates a positive feed back loop, and CcpA self-regulates 
its own expression. Glu: glucose, Gal: galactose, SF: sodium formate. The green arrow indicates increase in 
expression, whereas the red arrow is for decreased expression. *Posttranslational activation of PFL by PFL-AE 
has been previously reported9,47.
www.nature.com/scientificreports/
1 4Scientific RepoRts | 7:43587 | DOI: 10.1038/srep43587
Based on the available data we propose the model for pflA and pflB regulation shown in Fig. 8. Growth on 
galactose increases PFL activity, which leads to increased production of formate, and also induces glnR expression. 
When the formate level reaches a certain threshold, GlnR repression over pflA and pflB expression is removed, 
and GlnR then binds to cre, up-regulating ccpA transcription. In addition, the increased formate production also 
increases ccpA expression as well as CcpA affinity for PpflB, leading to an increase in pflB transcription. However, 
CcpA and GlnR also bind to PpflA, and repress pflA expression to fine-tune the level of pflA transcript. On the 
other hand, on glucose, GlnR increases ccpA expression, and CcpA activates its own expression. This, in turn, 
results in repression of both pflA and pflB, and pyruvate is dissimilated mainly to lactate by lactate dehydrogenase 
activity1,2.
Galactose is found in high concentration on host glycoconjugates in the nasopharynx, where the pneumococ-
cus resides, and the microbe is able to cleave and utilize galactose from these sources8. However, galactose is not 
efficiently catabolized by the pneumococcus, possibly due to the possession of low-affinity galactose importers6, 
and/or to a slow association rate between nascent PFL and PFL-AE for the formation of active PFL32. In addi-
tion, at the transcriptional level the expression of pflA and pflB is down-regulated by the regulators identified in 
this study, with the exception of CcpA, in the presence of galactose. Taken together, these data indicate that the 
pneumococcus has evolved to catabolize galactose at a lower rate than other sugars, such as glucose. It can be 
speculated that low galactose catabolic rate allows the microbe to maintain a stable relationship with its host. This 
can be linked to galactose catabolism and its role in pneumococcal virulence. For example, the pneumococcus 
produces more capsule, an essential virulence determinant, on galactose than it does on glucose10.
This study demonstrates that PFL synthesis is fine-tuned at the transcriptional level by multiple regulators and 
various environmental conditions. PFL activity is known to be crucial for galactose catabolism, which is linked to 
pneumococcal colonization and virulence. Detailed knowledge of regulation of pneumococcal sugar metabolism 
may allow identification of targets for new antiinfectives against this important pathogen.
Materials and Methods
DNA manipulations. Standard methods were used for chromosomal DNA isolation, restriction enzyme 
digestion, cloning, transformation, agarose gel electrophoresis, and sodium dodecyl sulphate polyacrylamide gel 
electrophoresis33. Plasmids were extracted using QIAprepSpin Miniprep Kit (Qiagen, UK), and PCR products 
were purified using the Wizard® SV Gel and PCR Clean-Up System (Promega, UK).
Bacterial strains, plasmids and growth conditions. The strains and plasmids used and constructed 
in this study are listed in Supplementary Table S2. Pneumococcal strains were grown microaerobically at 37 °C 
as described previously2. For anaerobic growth, an anaerobic cabinet was used. Pneumococci were also grown 
in chemically defined medium with selected sugars (CDM)1. Growth was monitored by measuring the optical 
density at 500 nm (OD500). Growth rates (μ ) were calculated through linear regressions of the plots of ln(OD500) 
versus time during the exponential growth phase. When required, the pneumococcal growth medium was sup-
plemented with spectinomycin (100 μ g/ml), tetracycline (15 μ g/ml), and kanamycin (250 μ g/ml).
Escherichia coli strains, used for cloning and protein expression, were grown in Luria Bertani (LB) broth with 
shaking at 37 °C or on LB agar plates. For E. coli cultures, ampicillin and kanamycin at 100- and 50 μ g/ml, respec-
tively, were used when required.
Microarray analysis. S. pneumoniae D39 and its isogenic mutant strain Δ pflB, deficient in pyruvate formate 
lyase (PFL) activity, were grown anaerobically in CDM supplemented with 55 mM galactose as the main carbon 
source. The experiments were repeated with four biological replicates. The MicroPrep software package was used 
to obtain the microarray data from the slides. CyberT implementation of a variant of t-test (http://bioinformatics.
biol.rug.nl/cybert/index.shtml) was performed and false discovery rates (FDRs) were calculated27. For differen-
tially expressed genes, p < 0.001 and FDR < 0.05 were taken as standard. For the identification of differentially 
expressed genes a Bayesian p-value of < 0.001 and a fold change cut-off twofold were applied. All other proce-
dures for the DNA microarray experiments and data analysis were performed as described before34.
Gene splicing by overlap extension (gene SOEing). Allelic replacement mutagenesis was achieved by 
transformation with an in vitro mutagenized SOEing construct. To do this, spectinomycin (SpecR) or kanamycin 
(KanR) resistance gene cassettes35,36 were amplified using the primes Spec-F and Spec-R or Kan-F and Kan-R 
primers (Supplementary Table S3). The primers LF-SOEX-F/LF-SOEX-R and RF-SOEX-F/RF-SOEX-R (where 
X indicates the gene code) were used to amplify the left and right flanking regions of each target gene, generating 
PCR products of approximately 600 bp in length. The amplified antibiotic resistance cassette and the PCR prod-
ucts flanking the target gene were then fused using LF-SOEX-F and RF-SOEX-R primers. The fused product 
was gel-purified after electrophoresis (Qiagen) and transformed into S. pneumoniae37. The transformants were 
selected on blood agar base supplemented with 5% (v/v) defibrinated horse blood containing the appropriate 
antibiotic and the mutations were confirmed by PCR and sequencing. The double mutant was constructed by 
transformation of amplicons representing the mutated region of glnR into the ccpA mutant.
Genetic complementation of mutants. To eliminate the possibility of polar effects, the mutant 
strains were genetically complemented using plasmid pCEP36. The wild type copy of mutated genes with their 
upstream sequence were amplified with X-Comp-F and X-Comp-R primers (where X indicates the gene code) 
(Supplementary Table S3). The amplicons were digested with NcoI-BamHI or SphI-BamHI and were ligated into 
similarly digested pCEP. A sample of ligation mixture was transferred into One Shot® TOP10 competent E. coli 
cells (Invitrogen, UK). The transformants were selected on kanamycin-containing LB agar plates, and successful 
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cloning was confirmed by PCR using Comp-Seq-F and Comp-Seq-R primers. The recombinant plasmid was 
purified, and a portion was transformed into the appropriate mutant strains. The complemented strains were 
designated as Δ ccpAComp, and Δ glnRComp.
Quantification of extracellular metabolites. Samples (2 ml) of anaerobic cultures growing in CDM 
containing 1% (w/v) glucose or galactose were collected at late exponential phase during growth, centrifuged 
(6700 × g, 10 min, 4 °C), filtered (Millex-GN 0.22 μ m filters) and the supernatant solutions were stored at − 20 °C 
until analysis with commercial kits for lactate, formate, and acetate detection (Megazyme, Ireland). The amount 
of organic acids produced by different strains was normalized to 1 × 108 cells. The spent culture supernates were 
obtained at late exponential phase and this corresponded to the following OD500s for the different strains grown 
on glucose and galactose, respectively: for D39 1.9 and 1.1; for Δ ccpA 1.8 and 0.7; for Δ glnR 1.2 and 0.6; for Δ 
ccpAΔ glnR 0.7 and 0.2.
Purification of recombinant proteins. The genes of interest were amplified and cloned into the hexa 
histidine-tagged, ampicillin resistant plasmid pLEICS-01 (PROTEX, University of Leicester) using the primers 
(Indicated with C-F/R in Supplementary Table S3) containing 15 nucleotides complementary to the cloning site 
in pLEICES-01. Recombinant plasmids were transformed into E. coli BL21 (DE3) pLysS (Agilent Tech, USA) for 
protein expression at 18 °C and 0.1 M of IPTG (Isopropyl β -D-1-thiogalactopyranoside) was used for induction of 
protein expression. When the OD600 reached 1.5–1.6, the culture was centrifuged and the pellet was resuspended 
with the binding buffer (20 mM Tris, 150 mM NaCl, pH 7.45) prior to sonication at an amplitude of 8 microns for 
15 sec with 45 sec intervals on ice. The lysate was then centrifuged and filtered through a 0.45 μ m acrodisc (Fisher 
Scientific, UK). Proteins were purified using PD-10 columns (GE Healthcare Life Sciences, UK) containing 2 ml 
of TALON Metal Affinity Resin (Clontech, USA) and finally eluted using different concentrations of imidazole 
elution buffer (20 mM Tris, 150 mM NaCl, pH 7.45). Protein fractions were dialysed against the binding buffer 
using Amicon Ultra-15 Centrifugal Filter Units (Millipore, UK) and the concentrations were determined using 
the Bradford protein assay38.
Electrophoretic mobility shift assay (EMSA). In silico analysis, using the bacterial promoter prediction 
tool (BPROM)39 and the Motif-based sequence analysis tools (MEME), was used to predict the presence of regu-
latory elements in the putative promoter regions of target genes40. Based on in silico analysis, primers (indicated 
by EMSA-F/R in Supplementary Table S3) were designed to amplify 95–100 bp DNA fragment representing puta-
tive promoter sites upstream of each gene.
EMSA was performed according to the protocol described previously41 using Molecular Probes 
fluorescence-based EMSA kit (Invitrogen). Briefly, 5X FY binding buffer (20 mM Tris-HCl pH 7.5, 30 mM KCl, 
1 mM DTT, 1 mM EDTA pH 8.0 and 10% v/v glycerol) was prepared to incubate the promoter probes and pro-
teins. The binding reaction was set up by mixing a constant amount of target promoter probes (~30 ng), and 
increasing amounts (0.1–0.5 μ M) of purified and dialysed His-tagged proteins. The binding reaction was incu-
bated at room temperature for 20 min in a total volume of 20 μ l, and then analysed on an 8% w/v non-denaturing 
polyacrylamide gel. After electrophoresis, gels were stained with SYBR® Green EMSA gel stain (Invitrogen) and 
visualized using a Typhoon Trio+ scanner (GE Healthcare Life Sciences) with a 526 nm short-pass wavelength 
filter.
Construction of lacZ-fusions. Chromosomal transcriptional lacZ-fusions to the target promoters were 
constructed via double crossover in the bgaA gene by using the integration plasmid pPP142. As the extracellular 
BgaA enzyme is responsible for removal of galactosides from complex carbohydrates, inactivation of the bgaA 
gene will not change the growth of S. pneumoniae in media and will not compromise regulatory studies42. The 
putative promoter regions were amplified using the primers modified to incorporate SphI and BamHI sites (indi-
cated with Fusion-F/R in Supplementary Table S3). The amplicons were digested with SphI and BamHI and were 
ligated into similarly digested pPP1. All plasmid constructs were confirmed by sequencing.
β-galactosidase assays. β -galactosidase activity was measured as described before43 using cells grown 
anaerobically in CDM at 37 °C supplemented with 55 mM of the selected sugars, or 10 mM sodium formate, and 
harvested in the mid-exponential phase of growth.
Total RNA purification and quantitative RT-PCR. The extraction of RNA was done by the Trizol 
method using mid-exponential phase cultures, as described previously44. Before use the RNA was treated with 
DNase using a TURBO DNA-free™ Kit (Ambion, UK), and subsequently purified with an RNeasy Mini Kit 
(Qiagen).
First strand cDNA was synthesized using approximately 1 μ g of DNase-treated total RNA, immediately after 
isolation, random hexamers and 200 U of SuperScript III reverse transcriptase (Invitrogen) at 42 °C for 55 min as 
described previously2. Three independent RNA preparations were used for qRT-PCR analysis. The transcription 
level of specific genes was normalized to gyrB transcription, which was amplified in parallel using the primers 
in Supplementary Table S4 (indicated with RT-F/R tags). cDNA samples obtained from individual biological 
samples were analysed in triplicates. The results were analysed by the comparative threshold cycle CT method45. 
Differences in expression of twofold or greater relative to control were considered as significant.
In vivo virulence studies. To evaluate the virulence of pneumococcal strains, nine to ten-week-old female 
MF1 outbred mice (Charles River, UK) were lightly anesthetized with 3% v/v isoflurane and oxygen mixture, and 
an inoculum of 50 μ l containing approximately 2 × 106 CFU in PBS was administered dropwise into the nostrils. 
Disease signs in infected animals were monitored regularly2,46. When the mice become lethargic, they were culled 
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by cervical dislocation, “survival time” was defined as the time to reach the lethargic state. Mice that were alive 
7 days after infection were deemed to have survived the infection. To monitor the development of bacteraemia, 
approximately 20 μ l of venous blood was obtained from each mouse at predetermined time points after infec-
tion, and viable counts were determined, as described above. Colonization experiments were done principally 
as described previously, using 5 × 105 CFU of S. pneumoniae in 10 μ l PBS, given intranasally8. Survival data were 
analysed by the Mann-Whitney test. Colonization and bacteraemia data were analysed by analysis of variance 
followed by Tukey’s multiple comparisons test. Statistical significance was considered to be a p-value of < 0.05.
Ethics statement. Mouse experiments at the University of Leicester were performed under appropriate 
project (permit no. 60/4327) and personal (permit no. 80/10279) licenses according to the United Kingdom 
Home Office guidelines under the Animals Scientific Procedures Act 1986, and the University of Leicester ethics 
committee approval. The protocol was approved by both the U.K. Home Office and the University of Leicester 
ethics committee. Where indicated, the procedures were carried out under anesthetic with isoflurone. Animals 
were housed in individually ventilated cages in a controlled environment, and were frequently monitored after 
infection to minimize suffering. Every effort was made to minimize suffering and in bacterial infection experi-
ments mice were humanely culled if they became lethargic.
Data Availabilty. Microarray data have been submitted to GEO (Gene Expression Omnibus) data-
base under the accession number GSE67668 (https://www.ncbi.nlm. nih.gov/geo/query/acc.cgi?token= 
ypkhqogmvhwrvst&acc=GSE67668).
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